One woman's journey from OCD to empowerment through comedy, offering hope and humor to others facing mental health challenges ...
Weill Cornell Medicine investigators have identified in a preclinical model a specific brain circuit whose inhibition appears ...
The U.S. Food and Drug Administration has approved a nose spray to help treat depression, Johnson & Johnson announced Tuesday.
An emerging treatment for clinical depression has reached an important milestone. This week, the Food and Drug Administration approved Johnson & Johnson’s ketamine-based nasal spray, Spravato, as a ...
The nasal spray Spravato, which is made from the drug esketamine, had been approved in 2019 for patients who failed to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback